|
2889
|
VA012
|
Positive allosteric modulator (PAM) of 5-HT2C receptor |
€105.00 |
|
3288
|
Vadadustat
|
Oral HIF-PH inhibitor and HIF stabilizer |
€80.00 |
|
2106
|
Valdecoxib
|
Selective COX-2 inhibitor |
€80.00 |
|
3127
|
Valproic acid sodium salt
|
Anti-convulsant |
€50.00 |
|
3106
|
Valsartan
|
Potent, highly selective, and orally active AT1 antagonist |
€76.00 |
|
1411
|
Vandetanib
|
VEGFR and EGFR tyrosine kinase inhibitor |
€50.00 |
|
3396
|
Vardenafil dihydrochloride
|
Highly potent, selective and orally bioavailable inhibitor of cGMP-specific PDE5 |
Recently added
|
€60.00 |
|
1384
|
Varenicline dihydrochloride
|
Nicotinic acetylcholine receptor agonist |
€80.00 |
|
2074
|
Varenicline tartrate
|
Selective α4β2 nicotinic acetylcholine receptor (nAChR) partial agonist |
€80.00 |
|
1867
|
Vasopressin antagonist 1867
|
Orally available and selective V1b receptor antagonist |
€125.00 |
|
1637
|
Vatalanib
|
VEGFR tyrosine kinase inhibitor |
€75.00 |
|
1893
|
VE 821
|
Inhibitor of the DNA damage response kinase ATR |
€80.00 |
|
2452
|
VE 822
|
Selective ATR inhibitor that decreases survival of pancreatic cancer cells |
€110.00 |
|
3173
|
Velpatasvir
|
Hepatitis C virus NS5A inhibitor |
€50.00 |
|
1727
|
Venlafaxine hydrochloride
|
SNRI |
€65.00 |